Chemical Intermediate CAS 135-07-9 Methyclothiazide Raw Materials Methyclothiazide API Methyclothiazide

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: D-sung Methyclothiazide
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Adult
• State: Powder
• Purity: >99%
• Product Name: Methyclothiazide
• Name: Methyclothiazide Powder
• Appearance: White Powder
• Color: White
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Pharmaceutical
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 135-07-9
• Mf: C9h11cl2n3o4s2
• Logp: 3.53610
• Psa: 126.33000
• Einecs: 205-172-2
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• Production Capacity: 1000kg/Month

Product Description

Chemical Intermediate CAS 135-07-9 Methyclothiazide  Raw Materials Methyclothiazide API Methyclothiazide
 

Product Description

Product Details

 

Product name	Methyclothiazide
Appearance	White powder
Cas number	135-07-9
MF	C9H11Cl2N3O4S2

Methyclothiazide, with the chemical name of 6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazin-7-sulfonamide-1,1-dioxide, is an organic compound, with the chemical formula of C7H8ClN3O4S2, which is a thiazide diuretic compound.

Application&Function

1. Edematous disease: excrete excessive sodium and water in the body, reduce the volume of extracellular fluid, and eliminate edema. Common causes include congestive heart failure, cirrhosis and ascites, nephrotic syndrome, acute and chronic nephritis and edema, early chronic renal failure, sodium and water retention caused by adrenocortical hormone and estrogen treatment.
2. Hypertension: It can be used alone or in combination with other antihypertensive drugs, mainly for the treatment of primary hypertension.
3. Central or renal diabetes insipidus.
4. Nephrolithiasis: mainly used to prevent the formation of stones containing calcium salts.
5. It can also be used to relieve symptoms of frequent urination, urgency, and pain caused by urinary tract infections.

Specification